本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Kalvista Pharmaceuticals Inc

13.84
+0.07000.51%
成交量:4.46萬
成交額:61.33萬
市值:6.88億
市盈率:-3.72
高:13.89
開:13.89
低:13.53
收:13.77
資料載入中...
2023/03/09

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/31

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/10

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/01/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/09

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2023/01/05

重要事件披露

8-K - Current report
2022/12/30

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/27

重要事件披露

8-K - Current report
2022/12/08

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/12/08

重要事件披露

8-K - Current report
2022/10/17

重要事件披露

8-K - Current report
2022/09/08

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/09/08

重要事件披露

8-K - Current report
2022/08/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals